semaglutide prediabetes weight loss diabetes prevention trial Effect of 2.4 mg once weekly on 10‐year type 2 risk in adults with overweight or obesity - Wilkinson - 2023 - Obesity Efficacy and safety of once-weekly

Payment options accommodate the varied financial systems used by research organizations worldwide

For example, type 2 diabetes is more prevalent in people with bipolar disorder, schizophrenia, and depression than in people without those conditions

Researchers report the first blinded, randomized, sham-controlled evidence that a procedure called duodenal mucosal resurfacing may offer a safe and lasting way to maintain weight loss without ongoing medication

By improving blood glucose control in type 2 diabetes, it may actually reduce susceptibility to candidiasis compared to poorly controlled diabetes

Research suggests semaglutide may be associated with a four times higher risk of developing a rare form of blindness called nonarteritic anterior ischemic optic neuropathy when used to treat Type 2 diabetes, and a seven times higher risk when used for obesity